BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3014839)

  • 1. PRPP synthetase superactivity in lymphoblast lines.
    Becker MA; Losman MJ; Rimon D; Kim M
    Adv Exp Med Biol; 1986; 195 Pt A():51-8. PubMed ID: 3014839
    [No Abstract]   [Full Text] [Related]  

  • 2. Inherited phosphoribosylpyrophosphate synthetase superactivity due to aberrant inhibitor and activator responsiveness.
    Becker MA; Losman MJ; Simmonds HA
    Adv Exp Med Biol; 1986; 195 Pt A():59-66. PubMed ID: 3014841
    [No Abstract]   [Full Text] [Related]  

  • 3. Neurodevelopmental impairment and deranged PRPP and purine nucleotide synthesis in inherited superactivity of PRPP synthetase.
    Becker MA; Puig JG; Mateos FA; Jimenez ML; Kim M; Simmonds HA
    Adv Exp Med Biol; 1989; 253A():15-22. PubMed ID: 2483028
    [No Abstract]   [Full Text] [Related]  

  • 4. Phosphoribosylpyrophosphate synthetase superactivity: detection, characterization of underlying defects, and treatment.
    Becker MA
    Adv Exp Med Biol; 1984; 165 Pt A():91-96. PubMed ID: 6326492
    [No Abstract]   [Full Text] [Related]  

  • 5. Kinetic aspects of purine metabolism in cultured fibroblasts. A comparative study of cells from patients overproducing purines due to HGPRT deficiency and PRPP synthetase superactivity.
    Zoref E; de Vries A; Sperling O
    Monogr Hum Genet; 1978; 10():96-9. PubMed ID: 214700
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased purine nucleotide degradation in the central nervous system (CNS) in PRPP synthetase superactivity.
    Jiménez ML; Puig JG; Mateos FA; Ramos TH; Melián JS; Nieto VG; Becker MA
    Adv Exp Med Biol; 1989; 253A():9-13. PubMed ID: 2560341
    [No Abstract]   [Full Text] [Related]  

  • 7. [PRPP synthetase superactivity].
    Fujimori S
    Nihon Rinsho; 1996 Dec; 54(12):3309-14. PubMed ID: 8976111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superactivity of human phosphoribosyl pyrophosphate synthetase due to altered regulation by nucleotide inhibitors and inorganic phosphate.
    Becker MA; Losman MJ; Wilson J; Simmonds HA
    Biochim Biophys Acta; 1986 Jun; 882(2):168-76. PubMed ID: 2423135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal purine and pyrimidine metabolism in inherited superactivity of PRPP synthetase.
    Bory C; Chantin C; Boulieu R
    Adv Exp Med Biol; 1994; 370():15-8. PubMed ID: 7660879
    [No Abstract]   [Full Text] [Related]  

  • 10. NAD synthesis by erythrocytes in phosphoribosylpyrophosphate synthetase (PRPPs) superactivity.
    Micheli V; Simmonds HA
    Adv Exp Med Biol; 1989; 253A():1-7. PubMed ID: 2560329
    [No Abstract]   [Full Text] [Related]  

  • 11. Selective expression of phosphoribosylpyrophosphate synthetase superactivity in human lymphoblast lines.
    Losman MJ; Rimon D; Kim M; Becker MA
    J Clin Invest; 1985 Oct; 76(4):1657-64. PubMed ID: 2414323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superactive phosphoribosylpyrophosphate synthetase with altered regulatory and catalytic properties.
    Becker MA; Raivio KO; Bakay B; Adams WB; Nyhan WL
    Adv Exp Med Biol; 1980; 122A():387-92. PubMed ID: 6158850
    [No Abstract]   [Full Text] [Related]  

  • 13. Gout with superactive phosphoribosylpyrophosphate synthetase due to increased enzyme catalytic rate.
    Becker MA; Losman MJ; Itkin P; Simkin PA
    J Lab Clin Med; 1982 Apr; 99(4):495-511. PubMed ID: 6174658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphoribosylpyrophosphate synthetase superactivity. A study of five patients with catalytic defects in the enzyme.
    Becker MA; Losman MJ; Rosenberg AL; Mehlman I; Levinson DJ; Holmes EW
    Arthritis Rheum; 1986 Jul; 29(7):880-8. PubMed ID: 3017368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRPP and purine nucleotide metabolism in human lymphoblasts with both PRPP synthetase superactivity and HGPRT deficiency.
    Becker MA; Kim M; Husain K
    Adv Exp Med Biol; 1989; 253B():13-20. PubMed ID: 2481968
    [No Abstract]   [Full Text] [Related]  

  • 16. Mutant feedback-resistant phosphoribosylpyrophosphate synthetase associated with purine overproduction and gout. Phosphoribosylpyrophosphate and purine metabolism in cultured fibroblasts.
    Zoref E; De Vries A; Sperling O
    J Clin Invest; 1975 Nov; 56(5):1093-9. PubMed ID: 171280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in purine metabolism in cultured fibroblasts with HGPRT deficiency and with PRPP synthetase superactivity.
    Zoref-Shani E; Sperling O
    Adv Exp Med Biol; 1979; 122B():19-24. PubMed ID: 232629
    [No Abstract]   [Full Text] [Related]  

  • 18. Possible metabolic basis for GTP depletion in red cells of patients with PRPP synthetase superactivity.
    Giacomello A; Salerno C
    Adv Exp Med Biol; 1991; 309B():253-6. PubMed ID: 1664182
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence of a new type of phosphoribosylpyrophosphate synthetase with abnormal kinetic properties in hyperuricemias.
    Mousson B; Baltassat P
    Adv Exp Med Biol; 1984; 165 Pt B():1-4. PubMed ID: 6326493
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanisms of accelerated purine nucleotide synthesis in human fibroblasts with superactive phosphoribosylpyrophosphate synthetases.
    Becker MA; Losman MJ; Kim M
    J Biol Chem; 1987 Apr; 262(12):5596-602. PubMed ID: 3032938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.